Neutralizing Antibody against SARS-CoV-2 infection
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A fully human monoclonal antibody has been identified that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells by the researchers at Utrecht University, Erasmus Medical Center, and Harbour BioMed (HBM).

• Such a neutralizing antibody has the potential to alter the course of infection in the infected host, support virus clearance, or protect an uninfected individual that is exposed to the virus.

• Antibody binds to a domain that is conserved in both SARS-CoV and SARS-CoV-2, explaining its ability to neutralize both viruses.

• This cross-neutralizing feature of the antibody is very interesting and suggests it may have potential in the mitigation of diseases caused by future-emerging related coronaviruses.

Much more work is needed to assess whether this antibody can protect or reduce the severity of disease in humans.

The paper is titled, "A human monoclonal antibody blocking SARS-VoV-2 Infection", published in Nature Communications on 4 May'20:
Dr. A●●●●●l s●●●●a and 20 others like this3 shares